4.7 Review

Nanotechnology: Future of Oncotherapy

期刊

CLINICAL CANCER RESEARCH
卷 21, 期 14, 页码 3121-3130

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-14-1189

关键词

-

类别

资金

  1. Altman Goldstein Discovery Fellowship
  2. Ovarian Cancer Research Fund
  3. Foundation for Women's Cancer
  4. Cancer Prevention Research Institute of Texas (CPRIT) [RP101502, RP101489, RP110595]
  5. NIH [U54CA151668, P50CA083639, CA109298, P50CA098258, UH2TR000943, CA016672, U54CA96300, U54CA96297]
  6. CPRIT [RP110595, RP120214]
  7. Ovarian Cancer Research Fund Program Project Development Grant
  8. U.S. Department of Defense [OC120547, OC093416]
  9. Betty Ann Asche Murray Distinguished Professorship
  10. RGK Foundation
  11. Gilder Foundation
  12. Judi A. Rees Ovarian Cancer Research Fund
  13. Chapman Foundation
  14. Meyer and Ida Gordon Foundation
  15. Blanton-Davis Ovarian Cancer Research Program

向作者/读者索取更多资源

Recent advances in nanotechnology have established its importance in several areas including medicine. The myriad of applications in oncology range from detection and diagnosis to drug delivery and treatment. Although nanotechnology has attracted a lot of attention, the practical application of nanotechnology to clinical cancer care is still in its infancy. This review summarizes the role that nanotechnology has played in improving cancer therapy, its potential for affecting all aspects of cancer care, and the challenges that must be overcome to realize its full promise. (C) 2015 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据